XENTER, INC.

Profile

Company Names

XENTER, INC.

Addresses

344 WEST 13800 SOUTH, STE. 400, DRAPER, UT 84020

2463 SOUTH 3850 WEST, SALT LAKE CITY, UT 84120

2463 S. 3850 W., SALT LAKE CITY, UT 84119

Phone Numbers

3857996400
8015190300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$23,531,012.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-12-23 
$1,131,800.00 
$40,000,000.00 
$38,868,200.00 
Equity 
2
2021-06-30 
$19,595,500.00 
$20,000,000.00 
$404,500.00 
Debt 
1
2020-12-31 
$2,803,712.00 
$12,000,000.00 
$9,196,288.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BAXTER 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
BEARSS 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
RICHARD 
 
LINDER 
EXECUTIVE OFFICER, DIRECTOR
ERIC 
 
PEARSON 
EXECUTIVE OFFICER
DAVID 
 
SAMPSON 
EXECUTIVE OFFICER
MARK 
 
STAUTBERG 
DIRECTOR
JAMES 
 
TOBIN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2021-06-30 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2022-12-23 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2021-06-30 
D
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2020-12-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#